 Our approach is a little more, I don't know, philosophical in that we try to figure out how the normal tissue is disrupted and maybe figure out, knowing the mechanisms for that, how we can restore health to the cancer tissue, kind of restore it back to more of a normal state. And that's why we're working on these two pathways.